Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IFEROS – Influence of intravenous iron therapeutics on oxidative stress in hemodialysis patients
2006-005916-29Phase 4Active
- Sponsor
- Westpfalz-Klinikum
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Iron in anemia of renal disease and chronic kidney disease (CKD), sponsored by Westpfalz-Klinikum. Primary endpoints: Oxidative stress in peripheral blood leukocytes and Apoptotic changes in peripheral blood leukocytes. Started Jun 2007; status: active.
02
Drugs
Iron
03
Conditions
anemia of renal diseasechronic kidney disease (CKD)
Beyond the preview
Go deeper on 2006-005916-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005916-29.